In other countries
The same active substances on other registers, the same brand first.
- HyrimozBrazil · Sandoz do Brasil Indústria Farmacêutica LtdaSame brand
- Hyrimoz 40 MG Solucion Inyectable en Jeringa PrecargadaSpain · 40 mg · solución inyectable en jeringa precargada · Sandoz GmbhSame brand
- Hyrimoz 40 MG Solucion Inyectable en Jeringa PrecargadaSpain · 100 mg · solución inyectable y para perfusión en jeringa precargada · Sandoz GmbhSame brand
- Hyrimoz 40 MG Solucion Inyectable en Pluma PrecargadaSpain · 100 mg · solución inyectable y para perfusión en jeringa precargada · Sandoz GmbhSame brand
- HyrimozEuropean Union · Sandoz GmbHSame brand
- HyrimozCroatiaSame brand
- HyrimozItaly · Soluzione iniettabile · Sandoz GMBHSame brand
- Hyrimoz 20 mg, oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · Sandoz GmbHSame brand
- Hyrimoz 40 mg, oplossing voor injectie in voorgevulde penNetherlands · Oplossing voor injectie · Sandoz GmbHSame brand
- Hyrimoz 40 mg, oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · Sandoz GmbHSame brand
- HYRIMOZ 40 mgRomania · 40mg/0,8ml · sol inj. in pen preumplut · Sandoz GMBHSame brand
- HYRIMOZ 40 mgRomania · 40 mg · sol. inj. in pen preumplut · Sandoz GMBHSame brand
- Hyrimoz®Serbia · 40mg/0.8mL · rastvor za injekciju u napunjenom injekcionom penu · PredstavniŠTvo Sandoz Pharmaceuticals D.D. BeogradSame brand
- Hyrimoz®Serbia · 40mg/0.8mL · rastvor za injekciju u napunjenom injekcionom penu · PredstavniŠTvo Sandoz Pharmaceuticals D.D. BeogradSame brand
- HyrimozSaudi Arabia · SandozSame brand
- Hyrimoz Solution for Injection in Pre-Filled Pen 40MG/0.8MLSingapore · 40 mg/0.8 mL · injection, solution · Sandoz Singapore Pte. LTD.Same brand
- Hyrimoz Solution for Injection in Pre-Filled Pen 40MG/0.4MLSingapore · 40 mg /0.4 ml · injection, solution · Sandoz Singapore Pte. LTD.Same brand
- Hyrimoz Solution for Injection in Pre-Filled Syringe 20MG/0.2MLSingapore · 20 mg /0.2 ml · injection, solution · Sandoz Singapore Pte. LTD.Same brand
- HyrimozUnited States · 40MG/0.8ML · injectable · Sandoz INCSame brand
- HyrimozUnited States · 80MG/0.8ML · Injection · Sandoz Inc.Same brand
- HyrimozUnited States · 40MG/0.8ML · Injection · Sandoz Inc.Same brand
- AmgevitaBrazil · Amgen Biotecnologia do Brasil Ltda.Same substance
- AtenfeBrazil · Megalabs Farmaceutica S.A.Same substance
- AmgevitaEuropean Union · Amgen Europe B.V.Same substance
- AmsparityEuropean Union · Pfizer Europe MA EEIGSame substance
- AmgevitaCroatiaSame substance
- HukyndraCroatiaSame substance
- AmgevitaItaly · Soluzione iniettabile · Amgen Europe B.V.Same substance
- HefiyaItaly · Soluzione iniettabile · Sandoz GMBHSame substance
- AmgevitaNew Zealand · Inj 20 mg per 0.4 ml prefilled syringeSame substance
- AmgevitaNew Zealand · Inj 40 mg per 0.8 ml prefilled penSame substance
- AmgevitaNew Zealand · Inj 40 mg per 0.8 ml prefilled syringeSame substance
- AMGEVITA 40 mgRomania · 40mg/0.8ml · sol inj. in seringa preumpluta · Amgen Europe B.V.Same substance
- Idacio®Serbia · 40mg/0.8mL · rastvor za injekciju u napunjenom injekcionom špricu · Fresenius Kabi D.O.O. BeogradSame substance
- AbriladaSaudi Arabia · CatalentSame substance
- AmgevitaSaudi Arabia · Amgen Manufacturing LtdSame substance
- Yuflyma 40 mg solution for injectionTaiwan · 注射劑 · 台灣賽特瑞恩有限公司Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Adalimumab
- Strength
- 40 MG / 0.8 ML
- Dosage form
- Solution
- Route
- Subcutaneous
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 15 Feb 2021
- Registration
- DIN 02492164
- Marketing authorisation holder
- Sandoz Canada Incorporated
- ATC code
- L04AB04
- Supply
- PRESCRIPTION, SCHEDULE D